iShares Genomics Immunology and Healthcare ETF
IDNA
IDNA
53 hedge funds and large institutions have $41.3M invested in iShares Genomics Immunology and Healthcare ETF in 2024 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 21 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
62% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 21
Holders
53
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.35M | |
| 2 | +$442K | |
| 3 | +$296K | |
| 4 |
OIA
OneDigital Investment Advisors
Overland Park,
Kansas
|
+$252K |
| 5 |
AWM
Avior Wealth Management
Omaha,
Nebraska
|
+$234K |
Top Sellers
| 1 | -$4.23M | |
| 2 | -$1.74M | |
| 3 | -$903K | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$465K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$397K |